INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2019

In aged men, oral nicotinamide riboside elevated the muscle NAD+ metabolome and lowered circulating inflammatory cytokines without altering bioenergetics.

In a randomized, double-blind, placebo-controlled crossover study, 12 aged men received 1 g per day of oral nicotinamide riboside (NR) or placebo for 21 days. Targeted metabolomics demonstrated that NR increased the muscle NAD+ metabolome, as shown by higher nicotinic acid adenine dinucleotide and nicotinamide clearance products. Muscle RNA sequencing showed downregulation of energy metabolism and mitochondrial pathways, though mitochondrial bioenergetics were not altered. Additionally, NR supplementation reduced circulating inflammatory cytokine levels.

Study type
Placebo-controlled, randomized, double-blind, crossover trial
Who was studied
12 aged men
What was measured
Skeletal muscle NAD+ metabolome, muscle mitochondrial bioenergetics, muscle gene expression, and circulating inflammatory cytokines

THE PAPER

Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.

Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, Cartwright DM, Oakey L, Burley CV, Jenkinson N, Wilson M, Lucas SJE, Akerman I, Seabright A, Lai YC, Tennant DA, Nightingale P, Wallis GA, Manolopoulos KN, Brenner C, Philp A, Lavery GG. Cell Rep, 2019.

PubMed 31412242 ↗DOI 10.1016/j.celrep.2019.07.043 ↗

Nutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.